Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02412696 · ClinicalTrials.gov registry record · NA

Positive Airway Pressure, Sleep Apnea, and the Placenta (PAP-SAP)

A NA study of Obesity and Pregnancy, sponsored by The Miriam Hospital.

Active
Registry status
NA
Development phase
262
Enrollment target
1
Study location

NCT02412696 is a NA study of Obesity and Pregnancy that is active but no longer recruiting, run by The Miriam Hospital. The registered enrollment target is 262 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02412696, a NA study of Obesity and Pregnancy, is active but no longer recruiting, sponsored by The Miriam Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
262 participants
Enrollment target
1
Study location

Study Summary

This study is testing the hypothesis of whether continuous positive airway pressure (CPAP) therapy improves placental histopathology and secretory function. The main aims of the study are to identify shared mechanisms between obstructive sleep apnea and preeclampsia, both common highly morbid conditions.

Interventions

  • DEVICE Positive Airway Pressure
  • OTHER Nasal Dilator Strips

Study Locations (1)

Rhode Island

  • The Miriam Hospital - Providence

Trial Details

FieldValue
Enrollment Target 262 participants
Start Date 2015-06-01
Est. Completion 2025-05-01
Phase NA

Sponsor

The Miriam Hospital

136 total trials

What the Registry Record Tells You About NCT02412696

The ClinicalTrials.gov registry entry for NCT02412696 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 262 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (68% lower). The listed sponsor is The Miriam Hospital, which has 136 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Positive Airway Pressure is the first listed.

NCT02412696 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.

Frequently Asked Questions

What is clinical trial NCT02412696 about?

NCT02412696 is a clinical study titled "Positive Airway Pressure, Sleep Apnea, and the Placenta (PAP-SAP)". This study is testing the hypothesis of whether continuous positive airway pressure (CPAP) therapy improves placental histopathology and secretory function. The main aims of the study are to identify shared mechanisms between obstructive sleep apnea and preeclampsia, both common highly morbid condit...

What is the current status of trial NCT02412696?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 262 participants. The study started on 2015-06-01. Estimated completion is 2025-05-01.

What conditions does trial NCT02412696 study?

This clinical trial studies the following conditions: Obesity, Pregnancy, Obstructive Sleep Apnea, Sleep, Preeclampsia.

What interventions are being tested in trial NCT02412696?

The interventions under investigation include: Positive Airway Pressure (DEVICE), Nasal Dilator Strips (OTHER).

Who is sponsoring clinical trial NCT02412696?

This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02412696 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.